An ingredient, several products
Semaglutide is the active ingredient in Wegovy, Ozempic, and Rybelsus. Product indications and formulations differ. A discussion about semaglutide should identify the specific medicine and the condition being treated rather than treating brand names as interchangeable.
Approved and compounded products
Compounded semaglutide is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness, or quality before marketing. Ask your prescriber what product is proposed, where it comes from, and why it fits your medical needs.
Safety belongs in the first conversation
Semaglutide product labeling includes a boxed warning about thyroid C-cell tumors observed in rodents; the relevance to humans is unknown. Personal or family history of medullary thyroid carcinoma or MEN2 is a contraindication. Discuss other medical conditions, medication interactions, gastrointestinal symptoms, pregnancy plans, and planned anesthesia with your clinician.
Planning an evaluation
Review candidacy, alternative treatments, expected follow-up, and costs before starting. Response varies, and an article cannot determine whether a prescription is appropriate. Use our program page for care information and the pricing page for questions to clarify with the office.